Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Paweł Sobczuk

Medical University of Warsaw

Poland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

50%

Immunology

40%

Oncology

50%

Cancer Therapy

40%

Targeted Therapy

40%

Sarcoma Research

30%

Cancer Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Prevalence and factors associated with professional burnout in Polish oncologists—results of a nationwide survey

Article Link

Year:

2024

Reinventing ESMO after the COVID-19 pandemic: moving towards a sustainable academic society

Article Link

Year:

2024

Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma

Article Link

Year:

2024

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

Article Link

Year:

2023

In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma

Article Link

Year:

2023

Brain metastases of sarcoma: a rare phenomenon in rare tumours

Article Link

Year:

2023

Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application

Article Link

Year:

2023

Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma

Article Link

Year:

2022

Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications

Article Link

Year:

2022

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence

Article Link

Year:

2022

Are medical students interested in research? – students’ attitudes towards research

Article Link

Year:

2022

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma

Article Link

Year:

2022

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study

Article Link

Year:

2022

What is the best front-line approach in patients with desmoid fibromatosis? – A retrospective analysis from a reference center

Article Link

Year:

2021

Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function

Article Link

Year:

2021

Collaborators14

Paweł Teterycz

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Anna Brodziak

Medical University of Warsaw

POLAND

Marcin Kleibert

Medical University of Warsaw

POLAND

Rebecca Lee

The University of Manchester

UNITED KINGDOM

Jan Poleszczuk

Assistant Professor

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

POLAND

Matthias Scheffler

University Hospital Bonn

GERMANY

Tomasz Switaj

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

Kamil Drucis

Medical University of Gdansk

POLAND

Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Wieslaw Bal

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

Magdalena Rosińska

current position: Head of Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Piotr Rutkowski

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

POLAND

Agnieszka Cudnoch-Jędrzejewska

Medical University of Warsaw

POLAND

How do I reach out?

Meet Kite AI